Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 951

  • Showing results for a modified search because your search retrieved no results.
1.
3.

The biopersistence of brazilian chrysotile asbestos following inhalation.

Bernstein DM, Rogers R, Smith P.

Inhal Toxicol. 2004 Oct-Nov;16(11-12):745-61.

PMID:
16036745
4.

The biopersistence of Canadian chrysotile asbestos following inhalation.

Bernstein DM, Rogers R, Smith P.

Inhal Toxicol. 2003 Nov;15(13):1247-74. Erratum in: Inhal Toxicol. 2004 Jan;16(1):67.

PMID:
14569492
6.
7.

A meta-analysis of asbestos-related cancer risk that addresses fiber size and mineral type.

Berman DW, Crump KS.

Crit Rev Toxicol. 2008;38 Suppl 1:49-73. doi: 10.1080/10408440802273156.

PMID:
18686078
8.
9.

The health effects of chrysotile: current perspective based upon recent data.

Bernstein DM, Hoskins JA.

Regul Toxicol Pharmacol. 2006 Aug;45(3):252-64. Epub 2006 Jul 11. Review.

PMID:
16814911
10.

Quantification of the pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite-asbestos following short-term inhalation exposure.

Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE.

Inhal Toxicol. 2011 Jun;23(7):372-91. doi: 10.3109/08958378.2011.575413. Erratum in: Inhal Toxicol. 2012 Jan;24(1):80.

PMID:
21639707
11.

The importance of fiber biopersistence and lung dose in determining the chronic inhalation effects of X607, RCF1, and chrysotile asbestos in rats.

Hesterberg TW, Hart GA, Chevalier J, Miiller WC, Hamilton RD, Bauer J, Thevenaz P.

Toxicol Appl Pharmacol. 1998 Nov;153(1):68-82.

PMID:
9875301
12.

The pathological response and fate in the lung and pleura of chrysotile in combination with fine particles compared to amosite asbestos following short-term inhalation exposure: interim results.

Bernstein DM, Rogers RA, Sepulveda R, Donaldson K, Schuler D, Gaering S, Kunzendorf P, Chevalier J, Holm SE.

Inhal Toxicol. 2010 Sep;22(11):937-62. doi: 10.3109/08958378.2010.497818. Erratum in: Inhal Toxicol. 2012 Jan;24(1):80.

PMID:
20695727
13.

Persistence of long, thin chrysotile asbestos fibers in the lungs of rats.

Coin PG, Roggli VL, Brody AR.

Environ Health Perspect. 1994 Oct;102 Suppl 5:197-9. Review.

14.

A biopersistence study following exposure to chrysotile asbestos alone or in combination with fine particles.

Bernstein DM, Donaldson K, Decker U, Gaering S, Kunzendorf P, Chevalier J, Holm SE.

Inhal Toxicol. 2008 Sep;20(11):1009-28. doi: 10.1080/08958370802259053 . Erratum in: Inhal Toxicol. 2012 Jan;24(1):80.

15.

Macrophage-associated responses to chrysotile.

Oberdörster G.

Ann Occup Hyg. 1994 Aug;38(4):601-15, 421-2.

PMID:
7978983
16.

Inferences on the kinetics of asbestos deposition and clearance among chrysotile miners and millers.

Finkelstein MM, Dufresne A.

Am J Ind Med. 1999 Apr;35(4):401-12.

PMID:
10086201
17.
18.

The health risk of chrysotile asbestos.

Bernstein DM.

Curr Opin Pulm Med. 2014 Jul;20(4):366-70. doi: 10.1097/MCP.0000000000000064. Review. Erratum in: Curr Opin Pulm Med. 2015 Jan;21(1):109. Curr Opin Pulm Med. 2014 Sep;20(5):525.

PMID:
24811832
19.

Fibers in lung tissues of mesothelioma cases among miners and millers of the township of Asbestos, Quebec.

Dufresne A, Harrigan M, Massé S, Bégin R.

Am J Ind Med. 1995 Apr;27(4):581-92.

PMID:
7793429
20.

Biopersistence of synthetic vitreous fibers and amosite asbestos in the rat lung following inhalation.

Hesterberg TW, Chase G, Axten C, Miller WC, Musselman RP, Kamstrup O, Hadley J, Morscheidt C, Bernstein DM, Thevenaz P.

Toxicol Appl Pharmacol. 1998 Aug;151(2):262-75. Erratum in: Toxicol Appl Pharmacol 1999 Mar 15;155(3):292.

PMID:
9707503

Supplemental Content

Support Center